Anne Kessinger
Overview
Explore the profile of Anne Kessinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ettinger D, Akerley W, Borghaei H, Chang A, Cheney R, Chirieac L, et al.
J Natl Compr Canc Netw
. 2012 Oct;
10(10):1236-71.
PMID: 23054877
Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are...
12.
Miller S, Alam M, Andersen J, Berg D, Bichakjian C, Bowen G, et al.
J Natl Compr Canc Netw
. 2012 Mar;
10(3):312-8.
PMID: 22393193
No abstract available.
13.
Ettinger D, Akerley W, Borghaei H, Chang A, Cheney R, Chirieac L, et al.
J Natl Compr Canc Netw
. 2012 Jan;
10(1):26-41.
PMID: 22223867
No abstract available.
14.
Wang J, Wang F, Kessinger A
Adv Urol
. 2011 Jul;
2011:693964.
PMID: 21785585
Background. The objective of this paper was to examine the epidemiology, natural history, and prognostic factors of carcinosarcoma of the kidney and renal pelvis (CSKP) using population-based registry. Patients and...
15.
Wang J, Wang F, Kessinger A
World J Urol
. 2011 Jun;
30(6):777-83.
PMID: 21706144
Background: Signet-ring cell carcinoma (SRCC) of the urinary bladder is a rare entity. No previous studies have directly compared the cancer-specific survival of patients with SRCC to patients with urothelial...
16.
Ganti A, Siedlik E, Marr A, Loberiza Jr F, Kessinger A
Am J Clin Oncol
. 2011 Jan;
34(6):593-6.
PMID: 21217398
Background: The effect of age and/or comorbidities on management decisions in lung cancer patients has been debated. The Charlson Comorbidity Index (CCI) was developed to help predict mortality from chronic...
17.
Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer
Ganti A, Kessinger A
Cancer Treat Rev
. 2011 Jan;
37(6):440-3.
PMID: 21216106
While basal cell carcinoma (BCC) is the most common human malignancy, distant metastases from this are rare. Current therapy for disseminated BCC is based on anecdotal reports in the absence...
18.
Ganti A, West W, Lackner R, Kessinger A
Oncology (Williston Park)
. 2010 Dec;
24(11):1034-9.
PMID: 21155454
Despite a decreasing incidence in the United States, small-cell lung cancer (SCLC) remains a major clinical problem, with approximately 30,000 new cases each year. The diagnosis of SCLC is usually...
19.
Ettinger D, Akerley W, Bepler G, Blum M, Chang A, Cheney R, et al.
J Natl Compr Canc Netw
. 2010 Nov;
8(11):1302-15.
PMID: 21081786
No abstract available.
20.
Wang J, Wang F, Kessinger A
J Oncol
. 2010 Sep;
2010.
PMID: 20871663
Background. The objective of this study was to examine the epidemiology, natural history, and prognostic factors of combined hepatocellular and cholangiocarcinoma (cHCC-CC) using population-based registry. Methods. The Surveillance, Epidemiology, and...